Tue, Oct 21, 2014, 5:49 AM EDT - U.S. Markets open in 3 hrs 41 mins


% | $
Quotes you view appear here for quick access.

Elan Corporation, plc Message Board

  • acricketeer acricketeer Jun 30, 2003 8:57 AM Flag

    Forgive Me For Pumping but

    I think the stock could more than double in one day with the announcement of positve results for Crohn's. With that said, I would think the stock would drop below 2 1/2 on missing their primary endpoint. The real question for speculators is whether they could get an interim peek at the data without skewing the results. There is a way of doing that but it all depends on the disease studied. If it's a standalone study and a large number of CD patients showed improvement without taking steroids, one could factor in all the placebo patients and still get a good clue for the outcome. To my knowledge, fistulas just don't disappear spontaneously over a short time. I think the Company is keeping the trial design under wraps for competitive reasons. If anyone knows anything about the trial design, please share it.
    For speculators, look at the August calls. The implieds are high, but not exorbitant and may offer a better risk reward than the stock. Also, I expect the implieds to go up in the face of decay as we get closer to the unblinding, because the shorts will have to hedge by buying calls. Julys are too soon.


Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
NCR Corp.
NYSEMon, Oct 20, 2014 4:02 PM EDT